You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ruxolitinib

Showing 1 - 25 of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ruxolitinib in Patients With Myelofibrosis

Completed
  • Myelofibrosis
  • Ruxolitinib
  • (no location specified)
Jun 5, 2022

Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)

Completed
  • Necrobiosis Lipoidica
  • Ruxolitinib
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Mar 17, 2022

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • Ruxolitinib
  • (no location specified)
Mar 7, 2022

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Canton, Ohio
    Gabrail Cancer Center
Aug 3, 2022

Myelofibrosis Trial in Jinan (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Ruxolitinib
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jul 3, 2022

T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,

Completed
  • T Cell Leukemia, Adult
  • +2 more
  • Ruxolitinib
  • ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022

Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)

Enrolling by invitation
  • Discoid Lupus Erythematosus
  • Ruxolitinib
  • Rochester, New York
    UR Medicine Dermatology College Town
May 20, 2022

Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)

Not yet recruiting
  • Macrophage Activation Syndrome
  • (no location specified)
Mar 16, 2022

Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)

Recruiting
  • Chronic Hand Dermatitis
  • Ruxolitinib
  • Rochester, New York
    UR Medicine Dermatology College Town
Aug 9, 2022

Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)

Terminated
  • Myelofibroses
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 16, 2021

Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)

Recruiting
  • Hematopoietic Stem Cell Transplant (HSCT)
  • Bronchiolitis Obliterans (BO)
  • Ruxolitinib
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 6, 2022

Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Long-term Follow-up
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Steroid Refractory Graft Versus Host Disease
  • Cellular Therapy
  • Ruxolitinib
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Saint Louis, Missouri
    Washington University School of Medicine
May 6, 2022

COVID-19 Trial (Ruxolitinib)

No longer available
  • COVID-19
  • Ruxolitinib
  • (no location specified)
Dec 1, 2021

Bronchiolitis Obliterans Syndrome, Hematologic Malignancy Trial in Hangzhou (Ruxolitinib)

Not yet recruiting
  • Bronchiolitis Obliterans Syndrome
  • Hematologic Malignancy
  • Ruxolitinib
  • Hangzhou, Zhejiang, China
    The first Affiliated Hospital of Zhejiang University
Jun 7, 2022

Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Ruxolitinib
  • (no location specified)
Jan 18, 2022

Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Coral Gables, Florida
  • +2 more
Jul 12, 2022

Other Cancer Trial in Boston (ruxolitinib)

Recruiting
  • Other Cancer
  • ruxolitinib
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
Dec 3, 2021

COVID-19 Trial (Ruxolitinib)

Withdrawn
  • COVID-19
  • Ruxolitinib
  • (no location specified)
Mar 3, 2021

Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg

Recruiting
  • Graft-versus-host-disease
  • +3 more
  • Ruxolitinib
  • +2 more
  • Moscow, Russian Federation
  • +1 more
Apr 4, 2022

Hodgkin Lymphoma Trial in United States (Ruxolitinib, Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Chicago, Illinois
  • +4 more
Feb 16, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata Trial run by the National Institute of

Recruiting
  • Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
  • Alopecia Areata
  • Ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022